Phase II, multicentre, randomised, double blind, placebo conntrolled pilot study to determine proof of efficacy, safety, tolerablility and pharmacokinetics of intravesical PSD597 in the symptomatic management of interstitial cystitis/painful bladder syndrome
Latest Information Update: 14 Jan 2021
At a glance
- Drugs Lidocaine (Primary) ; Sodium bicarbonate
- Indications Bladder disorders; Interstitial cystitis; Pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Plethora Solutions
- 10 Nov 2006 New trial record.